Technical analysis

Merck breaks below $139.50

Merck breaks below $139.50

Merck: ⬇️ Sell

– Merck broke sideways price range

– Likely to fall to support level 129.00

Merck recently broke below the support level 139.50 – the lower boundary of the sideways price range 139.50–151.50 that has held from the end of August. Buyers defended 139.50 twice, at the start of October (wave A) and at the end of October (wave i), while 151.50 capped every rally, including wave ii at the start of November. The breakdown also took the stock below the daily up trendline from June.

The breakout accelerated the active impulse wave iii of the C-wave of the ABC correction (2) from the end of August.

Given the strong bearish momentum, Merck can be expected to fall further toward the next support level 129.00 (target price for the completion of the active wave iii), which acted as resistance at the start of July. The stock fell for a second day today after Merck ended its Phase 3 trial of the blood cancer drug nemtabrutinib on the advice of an independent monitoring committee.

If 129.00 holds, Merck can correct up toward 139.50 (now resistance). A daily close back above 139.50 would cancel this bearish scenario.

Sellers stay in control below 139.50, with drug-pricing pressure on large-cap pharma adding to the headwinds.

Article Rating
Rate this post